Analyst Ratings for Candel Therapeutics Inc. (CADL)
CADL Rating Summary
CADL Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.67 (+237.4%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$16.67 (+237.4%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/28/2025 | Stephens | Sudan Loganathan | New Coverage | Overweight (N/A) |
15.00 (N/A) |
5.40 (4.94) |
-8.52% | Details |
| 10/21/2025 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
16.00 (N/A) |
5.54 (4.94) |
-10.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
